Conceptual Definition of Diabetes Treatment Medications: Covering Multiple Drug Classes

Details

This article is a technical reference regarding a ConceptualCohortDefinition utilizing FHIR Group Resource. The subject is diabetes treatment medications, encompassing numerous drug classes such as SGLT-2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, metformin, and insulins. The definition uses the 'Characteristic Combination' method set to 'any-of,' structuring it to include multiple drug classes with diverse mechanisms of action. Specifically, over 10 different drug groups are covered, ranging from SGLT-2 inhibitors to non-steroidal mineralocorticoid receptor antagonists. Such a comprehensive definition is highly valuable for capturing the multifaceted management of specific diseases (diabetes) in medical data. It enables the extraction of patient populations based on multiple combination therapies or diverse pathophysiological approaches. By utilizing FHIR standards, it becomes possible to handle data from different drug classes uniformly, facilitating application in research and clinical decision support systems.